Benzinga | Jul 28, 2021 04:48PM EDT

Soleno Therapeutics Q2 Adj. EPS $0.05 Up From $(0.16) YoY

Soleno Therapeutics (NASDAQ:SLNO) reported quarterly earnings of $0.05 per share. This is a 131.25 percent increase over losses of $(0.16) per share from the same period last year.